BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8453777)

  • 1. Lipoprotein(a) in diabetes mellitus.
    Ritter MM; Loscar M; Richter WO; Schwandt P
    Clin Chim Acta; 1993 Jan; 214(1):45-54. PubMed ID: 8453777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lp(a) serum concentrations in diabetes mellitus].
    Murakami J; Kumasaka K; Kawano K; Murakami T; Hayashi Y; Arakawa Y
    Rinsho Byori; 1994 Dec; 42(12):1273-8. PubMed ID: 7869592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipoprotein (a) in type 1 diabetic children and adolescents: relationships with HbA1c and subclinical complications.
    Willems D; Dorchy H; Dufrasne D
    Eur J Pediatr; 1996 Mar; 155(3):175-8. PubMed ID: 8929723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral atherosclerosis and serum lipoprotein(a) in diabetes.
    Wollesen F; Dahlén G; Berglund L; Berne C
    Diabetes Care; 1999 Jan; 22(1):93-8. PubMed ID: 10333909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipoprotein-a levels and glyco-metabolic control in insulin and non-insulin dependent diabetes mellitus.
    Westerhuis LW; Venekamp WJ
    Clin Biochem; 1996 Jun; 29(3):255-9. PubMed ID: 8740512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort.
    Maser RE; Usher D; Becker DJ; Drash AL; Kuller LH; Orchard TJ
    Diabetes Care; 1993 May; 16(5):755-8. PubMed ID: 8495616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients.
    Hernández C; Chacón P; García-Pascual L; Simó R
    Diabetes Care; 2001 Feb; 24(2):350-5. PubMed ID: 11213891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria.
    Kapelrud H; Bangstad HJ; Dahl-Jørgensen K; Berg K; Hanssen KF
    BMJ; 1991 Sep; 303(6804):675-8. PubMed ID: 1833011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinopathy as a predictor of other diabetic complications.
    El-Asrar AM; Al-Rubeaan KA; Al-Amro SA; Moharram OA; Kangave D
    Int Ophthalmol; 2001; 24(1):1-11. PubMed ID: 11998880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipoprotein(A) levels: a comparison between diabetic and non-diabetic patients with acute ischemic stroke.
    Holanda MM; Filizola RG; Costa MJ; Andrade RV; Silva JA
    Arq Neuropsiquiatr; 2004 Jun; 62(2A):233-6. PubMed ID: 15235723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients.
    Guerci B; Meyer L; Sommer S; George JL; Ziegler O; Drouin P; Angioï-Duprez K
    Diabetes Metab; 1999 Nov; 25(5):412-8. PubMed ID: 10592864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus.
    O'Brien T; Nguyen TT; Harrison JM; Bailey KR; Dyck PJ; Kottke BA
    Mayo Clin Proc; 1994 May; 69(5):430-5. PubMed ID: 8170193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications.
    Erem C; Değer O; Bostan M; Orem A; Sönmez M; Ulusoy S; Telatar M
    Acta Cardiol; 1999 Aug; 54(4):203-7. PubMed ID: 10511896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease.
    Laakso M; Pyörälä K
    Atherosclerosis; 1988 Nov; 74(1-2):55-63. PubMed ID: 3214481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin-dependent diabetes.
    Heesen BJ; Wolffenbuttel BH; Leurs PB; Sels JP; Menheere PP; Jäckle-Beckers SE; Nieuwenhuijzen Kruseman AC
    Eur J Clin Invest; 1993 Sep; 23(9):580-4. PubMed ID: 8243530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High serum lipoprotein(a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy.
    Kim CH; Park HJ; Park JY; Hong SK; Yoon YH; Lee KU
    Diabetes Care; 1998 Dec; 21(12):2149-51. PubMed ID: 9839109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.
    Rudberg S; Persson B
    Diabetes Care; 1995 Jul; 18(7):933-9. PubMed ID: 7555552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus.
    Senba H; Furukawa S; Sakai T; Niiya T; Miyake T; Yamamoto S; Ueda T; Torisu M; Minami H; Miyaoka H; Onji M; Tanaka K; Matsuura B; Tanigawa T; Hiasa Y; Miyake Y
    J Diabetes Complications; 2016 Jul; 30(5):923-7. PubMed ID: 26947887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
    Tarnow L; Rossing P; Nielsen FS; Hansen BV; Dyerberg J; Parving HH
    Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.